openPR Logo
Press release

Endocrine Testing Market Company Analysis and Forecast to 2023

04-21-2017 03:35 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Endocrine Testing Market Company Analysis and Forecast to 2023

Endocrine testing has been witnessing a widespread application since the last few years. Analysts expect the trend to rise steadily in the near future due to growing prevalence of obesity and diabetes across the world. In 2014, the global opportunity in endocrine testing was worth US$6.1 bn. Rising at a CAGR of 8.50% between 2015 and 2023, it is likely to increase to US$12.8 bn by 2023.

Browse the Complete Report Details for this Market at: http://www.transparencymarketresearch.com/endocrine-testing-market.html

The rise in the incidence of diabetes, propelled by the increasing geriatric as well as obese population, has fueled the application of endocrine testing in determining the insulin level in a human body. The prevalence of obesity, in general, has also boosted the demand for this technology significantly, as it leads to a number of life-threatening diseases such as cardiac disorders, stroke, hypertension, and several types of cancer.

Going forward, the unmet medical needs in emerging countries are likely to provide ample opportunities for this market to grow. Leading players are aggressively focusing on expanding their reach in these economies through mergers, acquisitions, and strategic partnerships with local players.

Commercial Laboratories to Remain Leading End User of Endocrine Testing

Physician offices, home-based tests, hospitals, ambulatory care centers, and commercial laboratories are the prime end users of endocrine testing technology. Among these, commercial laboratories acquired the leading position in 2014 and is projected to remain on the top throughout the forecast period. The presence of skilled professionals, increased usage of specialized diagnostics tools, and advanced diagnostics facilities are the prominent factors that have fueled the application of endocrine testing techniques in these laboratories over the recent past.

In near future, the advent of tele-health services is expected to increase the application of endocrine testing in commercial laboratories considerably. The adoption of this technology will also witness a significant rise in the home-based tests segment in the coming years, owing to the instant results provided by endocrine test kits.

Endocrine Testing to Report Fastest Growth Rate in Asia Pacific

The global endocrine testing market stretches across North America, Asia Pacific, Europe, and the Rest of the World. North America emerged as the key contributor to the revenue generated in this market in 2014 with a share of more than 40%. The growing preference for a healthy lifestyle among people has increased the adoption of this technology in this region.

Additionally, the continual advancements in technology are expected to escalate the application of endocrine testing in North America over the next few years. Asia Pacific, however, is likely to provide the market players with most promising opportunities in the near future, owing to the presence of untapped emerging countries. The demand for endocrine testing in Asia Pacific is anticipated to rise at the fastest CAGR of 10.30% during the period from 2015 to 2023.

Get the Sample PDF Report Containing the Upcoming Market Oppotunities at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1645

F-Hoffmann La Roche Ltd. and Abbott Laboratories lead the global market for endocrine testing. Other key players operating in this market are DiaSorin S.p.A., Bio-Rad Laboratories Inc., bioMerieux SA, Biomedical Diagnostics, Agilent Technologies, AB Sciex Pte. Ltd., LabCorp, Siemens AG, and Thermo Fisher Scientific Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endocrine Testing Market Company Analysis and Forecast to 2023 here

News-ID: 510728 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Endocrine

Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is
Endocrine testing market is driven by the increasing incidences of endocrine dis …
The endocrine system comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal, etc. These glands secrete hormones that regulate the body’s metabolism, growth, sexual development, and function. Endocrine tests help in assessing the normal functioning of the endocrine gland by checking the hormone levels. Get a sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/306?utm_source=openpr&utm_medium=Niranjan The tests detect the imbalance in hormonal levels. The various tests, their advantages, and uses are described
Endocrine Testing Market - Size, Share, 2026
Endocrine testing procedure consist of measuring concentration of endocrinal hormones in blood or urine. These hormones are precise marker for presence of endocrinal disease such as hypo/hyperthyroidism, infertility etc. Various endocrine glands present in body include pituitary glands, thyroid glands, hypothalamus, pancreas, and adrenal glands. Any imbalance in the hormones secreted by this glands leads to certain disorder therefore they are important marker to diagnose certain condition. Get PDF Research Brochure
Endocrine Testing Market: Research Methodology
The global endocrine testing market features a fairly oligopolistic structure with the top five players occupying a combined market share of 90.0% in 2014, finds Transparency Market Research (TMR). These companies are Siemens Healthineers, DiaSorin, Agilent Technologies, Abbott Laboratories, and F. Hoffmann-La Roche AG. Among the leading players, Roche emerged as the dominant players in 2014. The leading companies are developing advanced lab automation systems, next-generation sequencing platforms, endocrine test
Global Endocrine Testing Market: Regular Monitoring of Endocrine in Management o …
The global endocrine testing market features a fairly oligopolistic structure with the top five players occupying a combined market share of 90.0% in 2014, finds Transparency Market Research (TMR). These companies are Siemens Healthineers, DiaSorin, Agilent Technologies, Abbott Laboratories, and F. Hoffmann-La Roche AG. Among the leading players, Roche emerged as the dominant players in 2014. The leading companies are developing advanced lab automation systems, next-generation sequencing platforms, endocrine test